Tetsuya Kaiso
- Safety and efficacy of NVA237 once daily in Japanese patients: The GLOW4 trialBy Mitsuaki Sekiya, Tomotaka Kawayama, Yoshinosuke Fukuchi, Yota Takahashi, Tetsuya Kaiso, Kimitoshi Ikeda, Tim Overend and Donald BanerjiMitsuaki Sekiya1Juntendo University, Bunkyo-ku, Tokyo, JapanTomotaka Kawayama2Kurume University, Kurume-city, Fukuoka, JapanYoshinosuke Fukuchi1Juntendo University, Bunkyo-ku, Tokyo, JapanYota Takahashi3Primary Care, Novartis Pharma K.K.,, Tokyo, JapanTetsuya Kaiso3Primary Care, Novartis Pharma K.K.,, Tokyo, JapanKimitoshi Ikeda3Primary Care, Novartis Pharma K.K.,, Tokyo, JapanTim Overend4Primary Care, Novartis Horsham Research Centre, Horsham, United KingdomDonald Banerji5Primary Care, Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.